课题基金 / 基金详情

Mechanisms of Mammalian Double-Strand Break Repair

Mechanisms of Mammalian Double-Strand Break Repair
哺乳动物双链断裂修复机制
批准号:
10322874
负责人:
Richard T Pomerantz
金额:
$2.13万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2015
资助国家:
美国
项目状态:
已结题
起止时间:
2015-07-15 至 2021-06-30

项目摘要

项目成果

Richard T Pomerantz的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DNA polymerase q (Polq) is a unique polymerase-helicase fusion protein that promotes the mutagenic DSB repair pathway called microhomology-mediated end-joining (MMEJ), or alternative end-joining. Polq functions on 3’ single-strand DNA (ssDNA) overhangs generated by 5’-3’ exonuclease resection of DSBs, similar to the homologous recombination (HR) machinery. Polq promotes the survival of cancer cells that are deficient in HR due to BRCA1/2 mutations, and confers resistance to chemotherapeutic agents (i.e. ionizing radiation, etoposide). Thus, elucidating the molecular mechanisms of this relatively newly discovered pathway is a priority. How the large (290 kDa) full-length Polq protein performs MMEJ and is organized at the atomic and molecular level remains unclear. Our recently published in vitro studies indicate that attachment of the polymerase and helicase subdomains of Polq is essential for MMEJ. Additional published preliminary studies demonstrate that full-length Polq behaves primarily as monomers. Furthermore, a newly developed GFP reporter cellular assay reveals the existence of Polq-independent MMEJ mechanisms. We plan to fully elucidate the molecular basis of Polq-dependent MMEJ, solve the structure of full-length Polq using cryo-EM, and identify and characterize Polq- independent MMEJ mechanisms by developing the following aims: 1. To elucidate how Polq subdomains contribute to MMEJ; 2. To solve the cryo-EM structure of full-length Polq; 3. To investigate Polq-independent mechanisms of MMEJ. We expect that these studies will identify novel mechanisms of Polq and previously undiscovered MMEJ processes that likely contribute to genome instability and cellular resistance to genotoxic chemotherapy agents.
期刊论文(7)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1038/nsmb.2961
发表时间: 2015-03
期刊: NATURE STRUCTURAL & MOLECULAR BIOLOGY
影响因子: 16.8
作者: [Kent, Tatiana, Chandramouly, Gurushankar, McDevitt, Shane Michael, Ozdemir, Ahmet Y., Pomerantz, Richard T.]
通讯作者: Pomerantz, Richard T.
DOI: 10.1038/s41467-018-03483-7
发表时间: 2018-03-15
期刊: Nature communications
影响因子: 16.6
作者: [McDevitt S, Rusanov T, Kent T, Chandramouly G, Pomerantz RT]
通讯作者: Pomerantz RT
DOI: 10.1038/nsmb.3494
发表时间: 2017-12
期刊: Nature structural & molecular biology
影响因子: 16.8
作者: [Mateos-Gomez PA, Kent T, Deng SK, McDevitt S, Kashkina E, Hoang TM, Pomerantz RT, Sfeir A]
通讯作者: Sfeir A
DOI: 10.3390/genes7090067
发表时间: 2016-09-21
期刊: Genes
影响因子: 3.5
作者: [Black SJ, Kashkina E, Kent T, Pomerantz RT]
通讯作者: Pomerantz RT
Structure Based Design of Pol-theta inhibitors
  • 批准号:
    10323627
  • 项目类别:
  • 资助金额:
    $38.59万
  • 财政年份:
    2021
  • 负责人:
    Richard T Pomerantz
  • 依托单位:
Next-generation precision medicine for targeting recombination-deficient cancers
  • 批准号:
    9909705
  • 项目类别:
  • 资助金额:
    $29.9万
  • 财政年份:
    2020
  • 负责人:
    Richard T Pomerantz
  • 依托单位:
Mechanisms of RNA-DNA repair
  • 批准号:
    10336801
  • 项目类别:
  • 资助金额:
    $36.53万
  • 财政年份:
    2020
  • 负责人:
    Richard T Pomerantz
  • 依托单位:
PolQ as a novel therapeutic target in AML
  • 批准号:
    10545175
  • 项目类别:
  • 资助金额:
    $52.39万
  • 财政年份:
    2020
  • 负责人:
    Richard T Pomerantz
  • 依托单位:
海外基金